The end of the COVID-19 public health emergency could create unsurmountable hurdles. The post Psychedelic Therapy Industry Reels After Major...
Source: Streetwise Reports 03/21/2023 Treating traumatic brain injury with alternative pharmaceuticals is delicate work. Now one Canadian...
Clairvoyant Therapeutics is pleased to announce that the first clinical trial participant in Finland enrolled in CLA-PSY-201 has received their first...
The article Lucy Scientific Acquires Psychedelic Assets from Wesana Health was originally published on Microdose. Last month, a new psychedelic firm joined...
The CEO of Synthesis speaks out about the recent bankruptcy of the Dutch sister company that left the U.S. practitioner training program in upheaval. The...
The article News You Might Have Missed: March 20th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Analysts have long expected a contraction, but when it hit it still felt sudden and strange. The post The Psychedelics Finance Crunch Seen in the SXSW...
This year’s SXSW brought together psychedelic professionals and media celebrities for a festive and starry-eyed look at an arguably precarious industry. The...
The article Filament Health Announces FDA Approval Of Phase II Clinical Trial was originally published on Microdose. Filament Health has announced FDA...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical–stage natural psychedelic drug development company, today announced approval from...
